Novo Nordisk (NVO) backed MapLight Therapeutics will raise $258.9M in an IPO and private placement, Avalon Pernell of Bloomberg reports. The company sold 14.75M shares for $17 each.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Mixed options sentiment in Novo Nordisk with shares down 0.59%
- Novo Nordisk Shares (NVO) Slip after Largest Shareholder Proposes Major Board Shake-Up
- Midday Fly By: Netflix, TI reports weigh on markets
- Mixed options sentiment in Novo Nordisk with shares down 2.58%
- Trump Trade: Trump administration prepares new probe into pharma prices